Nephros Inc (NEPH)
NASDAQ:NEPH
Holding NEPH?
Track your performance easily

Nephros (NEPH) Income Statement

68 Followers

Nephros Income Statement

Last quarter (Q2 2024), Nephros's total revenue was $3.25M, a decrease of -8.06% from the same quarter last year. In Q2, Nephros's net income was $-289.00K. See Nephros’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 13.77M$ 14.24M$ 9.97M$ 10.22M$ 8.56M$ 10.33M
Cost of Revenue
$ 5.46M$ 5.83M$ 5.24M$ 4.58M$ 3.65M$ 4.25M
Gross Profit
$ 8.31M$ 8.40M$ 4.73M$ 5.63M$ 4.91M$ 6.08M
Operating Expense
$ 9.68M$ 10.00M$ 9.07M$ 8.88M$ 9.42M$ 9.39M
Operating Income
$ -1.37M$ -1.59M$ -4.33M$ -3.25M$ -4.50M$ -3.31M
Net Non Operating Interest Income Expense
$ 83.00K$ 62.00K$ -6.00K$ -31.00K$ -99.00K$ -195.00K
Other Income Expense
$ 8.00K$ -44.00K$ -64.00K$ -499.00K$ 77.00K$ 102.00K
Pretax Income
$ -1.29M$ -1.57M$ -4.28M$ -2.78M$ -4.53M$ -3.40M
Tax Provision
$ -739.00K-$ 4.28M-$ 0.00$ -225.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -1.29M$ -1.57M$ -7.38M$ -6.89M$ -4.77M$ -3.42M
Basic EPS
$ -0.21$ -0.15$ -1.43$ -0.80$ -0.52$ -0.45
Diluted EPS
$ -0.21$ -0.15$ -1.43$ -0.80$ -0.52$ -0.45
Basic Average Shares
$ 41.96M$ 10.39M$ 10.30M$ 10.02M$ 9.08M$ 7.54M
Diluted Average Shares
$ 41.96M$ 10.39M$ 10.30M$ 10.02M$ 9.08M$ 7.54M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 15.14M$ 15.83M$ 14.31M$ 13.47M$ 13.06M$ 13.64M
Net Income From Continuing And Discontinued Operation
$ -1.29M$ -1.57M$ -7.38M$ -6.89M$ -4.77M$ -3.42M
Normalized Income
$ -2.00M$ -1.24M$ -983.83K-$ -5.00M$ -3.57M
Interest Expense
----$ 110.00K$ 195.00K
EBIT
$ -1.29M$ -1.57M$ -4.26M$ -2.74M$ -4.42M$ -3.21M
EBITDA
$ -1.11M$ -1.36M$ -3.91M$ -2.49M$ -4.21M$ -3.01M
Currency in USD

Nephros Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis